Evaluation of the factors affecting the quality of life and total costs in epilepsy patients on monotherapy with carbamazepine and valproate.

Folia medica

Volumn 50, Issue 2, 2008, Pages 18-23

  Balabanov, Pavel P ^a   Zahariev, Zahary Iv ^a   Mateva, Nonka G ^a  

^a MEDICAL UNIVERSITY OF PLOVDIV   (Bulgaria)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; VALPROIC ACID;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL TRIAL; COST OF ILLNESS; ECONOMICS; EPILEPSY; FEMALE; HUMAN; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; QUALITY OF LIFE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTICONVULSANTS; CARBAMAZEPINE; COST OF ILLNESS; EPILEPSY; FEMALE; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE; TREATMENT OUTCOME; VALPROIC ACID;

EID: 50949106728     PISSN: 02048043     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)